Microglia and prion disease

Microscopy Research and Technique

Volumn 54, Issue 2, 2001, Pages 71-80

  Brown, David R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; NEURODEGENERATIVE DISEASES; NEURONS; NUCLEIC ACIDS;

CONDITION; INCUBATION PERIODS; INFECTIOUS AGENTS; ISOFORMS; MICROGLIA; NEURODEGENERATION; NEURODEGENERATIVE; NEURONAL PROTEINS; PRION DISEASE; PRION PROTEIN;

PROTEINS;

CYTOKINE; GLUTAMIC ACID; PRION PROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; ASTROCYTOSIS; CELL PROLIFERATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; MICROGLIA; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE;

EID: 0035879599     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1122     Document Type: Article

References (75)

1. Anderson CNG, Tolkovsky AM. 1999. A role for MAPK/ERK in sympathetic neuron survival: protection against p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J Neurosci19:664-673.
2. Betmouni S, Perry VH. 1999. The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate. Neuropathol Appl Neurobiol 25:20-28.
3. Betmouni S, Perry VH, Gordon JL. 1996. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74:1-5.
4. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A. 1996. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339-343.
5. Brown DR, 1998. Prion protein-overexpressing cells show altered response to a neurotoxic prion protein peptide. J Neurosci Res. 54:331-340.
6. Brown DR. 1999a. Prion protein expression aids cellular uptake and veratridine-induced release of copper. J Neurosci Res 58:717-725.
7. Brown DR. 1999b. Comment on: neurotoxicity of prion protein peptide 106-126 not confirmed. FEBS Lett 460:559-560.
8. Brown DR. 1999c. Prion protein peptide neurotoxicity can be mediated by astrocytes. J Neurochem 73:1105-1113.
9. Brown DR. 2000a. Prion protein peptides: Optimal toxicity and peptide blockade of toxicity. Mol Cell Neurosci 15:66-78.
10. Brown DR. 2000b. Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala 117 Val mutation. Biochem J 346:785-791.
11. Sc-like prion protein peptide inhibits the function of cellular prion protein. Biochem J (in press).
12. Brown DR, Besinger A. 1998. Prion protein expression and superoxide dismutase activity. Biochem J 334:423-426.
13. Brown DR, Mohn CM. 1999. Astrocytic glutamate uptake and prion protein expression. Glia 25 282-292.
14. Brown DR, Herms J, Kretzschmar HA. 1994. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 5:2057-2060.
15. Brown DR, Schmidt B, Kretzschmar HA. 1996a. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380:345-347.
16. Brown DR, Schmidt B, Kretzschmar HA. 1996b. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia 18:59-67.
17. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck TA, von Bohlen A, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar HA. 1997a. The cellular prion protein binds copper in vivo. Nature 390:684-687.
18. Brown DR, Schultz-Schaeffer WJ, Schmidt B, Kretzschmar HA. 1997b. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 146:104-112.
19. Brown DR, Schmidt B, Kretzschmar HA. 1997c. Expression of prion protein in PC12 is enhanced by exposure to oxidative stress. Int J Dev Neurosci 15:961-972.
20. Brown DR, Besinger A, Herms JW, Kretzschmar HA. 1998a. Microglial expression of the prion protein. Neuroreport 9:1425-1429.
21. Brown DR, Schmidt B, Kretzschmar HA. 1998b. A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia. Neurobiol Dis 4:410-422.
22. Brown DR, Schmidt B, Groschup MH, Kretzschmar HA. 1998c. Prion protein expression in muscle cells and toxicity of a prion protein fragment. Eur J Cell Biol 7:29-37.
23. Brown DR, Schmidt B, Kretzschmar HA. 1998d. A prion protein fragment interacts with PrP-deficient cells. J Neurosci Res 52:260-267.
24. Brown DR, Pitschke M, Riesner D, Kretzschmar HA. 1998e. Cellular effects of a neurotoxic prion protein peptide are related to its β-sheet content. Neurosci Res Comm 23:119-128.
25. Brown DR, Schmidt B, Kretzschmar HA. 1998f. Effects of copper on survival of prion protein knockout neurones and glia. J Neurochem 70:1686-1693.
26. Brown DR, Wong B-S, Hafiz F, Clive C, Haswell SJ, Jones IM. 1999. Normal prion protein has an activity like that of superoxide dismutase. Biochem J 344:1-5.
27. Brown DR , Hafiz F, Glasssmith LL, Wong B-S, Jones IM, Clive C, Haswell SJ. 2000. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J 19:1180-1186.
28. Bruce M, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ. 1997. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389:498-501.
29. Chabry J, Caughey B, Chesebro B. 1998. Specific inhibition of in vitro formation of protease restant prion protein by snthetic peptides. J Biol Chem 273:13203-13207.
30. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. 1996. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383:685-690.
31. Choi S-I, Ju W-K, Choi E-K, Kim J, Lea H-Z, Carp RI, Wisniewski HM, Kim Y-S. 1998. Mitochondial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol 96:279-286.
32. Sc causes nerve cell death and stimulates astrocyte proliferation: a paradox. Prog Brain Res 94:437-46.
33. Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey IIW, Haase AT. 1991. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apoliprotein E and cathespin D in astrocytes. J Virol 65:4759-4768.
34. De Gioia L, Selvaggini C, Ghibaudi E, Diomede L, Bugiani O, Forloni G, Tagliavini F, Salmona M. 1994. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. J Biol Chem 269:7859-7862.
35. Dodelet VC, Cashman NR. 1998. Prion protein expression in human leukocyte differentiation. Blood 91:1556-1561.
36. Ettaiche M, Pichot R, Vincent J-P, Chabry J. 2000. In vivo cytotoxicity of prion protein fragment PrP106-126. J Biol Chem 275:36487-36490.
37. Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C. 1996. Prion protein (PrP) with amino-proximal deletions restoring suceptability of PrP knockout mice to scrapie. EMBO J 15:1255-1264.
38. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F. 1993. Neurotoxicity of a prion protein fragment. Nature 362:543-546.
39. Forloni G, Del Bo R, Angeretti N, Chiesa R, Smiroldo S, Doni R, Ghibaudi E, Salmona M, Porro M, Verga L, Giaccone G, Bugiani O, Tagliavini F. 1994. A Neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur J Neurosci 6:1415-1422.
40. Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Bugiani O, Giaccone G, Prelli F, Goedert M, Dlouhy SR, Tagliavini F. 1996b. Vascular variant of prion protein cerebral amyloidosis with t-positive neurofibrillary tangles: the phenotype of the stop codom 145 mutation in PRNP. Proc Natl Acad Sci USA 93:744-748.
41. Ghetti B, Piccardo P, Frangione B, Bugiani O, Giaccone G, Young K, Prelli F, Farlow MR, Dlouhy SR, Tagliavini F. 1996a. Prion protein amyloidosis. Brain Pathol 6:127-145.
42. Giese A, Groschup MH, Hess B, Kretzschmar HA. 1995. Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 5:213-221.
43. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA. 1998. Role of microglia in neuronal cell death in prion disease. Brain Pathol 8:449-457.
44. Guan Z, Soderberg M, Sindelar P, Prusiner SB, Kristensson K, Dallner G. 1996. Lipid composition in scrapie-infected mouse brain: prion infection increases the levels of dolichyl phosphate and ubiquinone. J Neurochem 66:277-285.
45. Guentchev M, Voigtländer T, Haberler C, Groschup MH, Budka H. 2000. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis (in press).
46. Guiroy DC, Williams ES, Yanagihara R, Gajdusek D C. 1991. Immunolocalization of scrapie amyloid (PrP27-30) in chronic wasting disease of Rocky Mountain elk and hybrids of captive mule deer and white-tailed deer. Neurosci Lett 126:195-198.
47. Guiroy DC, Wakayama I, Liberski PP, Gajdusek DC. 1994. Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Straussler syndrome. Acta Neuropathol 87:526-530.
48. Hafiz F, Brown DR. 2000. A model of the mechanism of astrogliosis in prion disease. Mol Cell Neurosci 16:221-232.
49. Sc accumulation. J Virol 72:1153-1159.
50. Hope J, Reekie LJ, Hunter N, Multhaup G, Beyreuther K, White H, Scott AC, Stack MJ, Dawson M, Wells GA. 1988. Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature 336:390-392.
51. Ironside JW, McCardle L, Hayward PA, Bell JE. 1993. Ubiquitin immunocytochemistry in human spongiform encephalopathies. Neuropathol Appl Neurobiol 19:134-40.
52. Jaegly A, Boussin F, Deslys J-P, Dormont D. 1995. Human growth hormone related iatogenic Cretzfeld-Jakob disease: search for a genetic suseptability by analysis of the PRNP coding region. Genomics 27:382-383.
53. Jendroska K, Heinzel FP, Torchia M, Stowring L, Kretzschmar HA, Kon A, Stern A, Prusiner SB, DeArmond SJ. 1991. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology 41:1482-1490.
54. 2+. Neuron 10:797-804.
55. Kim JI, Ju W-K, Choi J-H, Kim J, Choi E-K, Carp RI, Wisniewski HM, Kim Y-S. 1999. Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Mol Brain Res 73:17-27.
56. Kunz B, Sandmeier E, Christen P. 1999. Neurotoxicity of prion peptide 106-126 not confirmed. FEBS Lett 458:65-68.
57. Lee DW, Sohn HO, Lim HB, Lee YG, Kim Y-S, Carp RI, Wisniewski HM. 1999. Alteration of free radical metabolism in the brain of mice infected with scrapie agent. Free Radic Res 30:499-507.
58. Marsh RF, Burger D, Eckroade R, Zu Rhein GM, Hanson RP. 1969. A preliminary report on the experimental host range of the transmissible mink encephalopathy agent. J Infect Dis 120:713-719.
59. McHattie SJ, Brown DR, Bird MM. 1999. Cellular uptake of the prion protein fragment PrP106-126 in vitro. J Neurocytol 28:145-155.
60. Miyazono M, Iwaki T, Kitamoto T, Kaneko Y, Doh-ura K, Tateishi J. 1991. A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol 139:589-598.
61. Moser M, Colello RJ, Pott U, Oesch B. 1995. Developmental expression of the prion protein gene in glial cells. Neuron 14:509-517.
62. Moynagh PN, Williams DC, O'Niell LAJ. 1993. Interleukin-1 activates transcriptional factor NF-κB in glial cells. Biochem J 294: 343-347.
63. Sc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 246:261-267.
64. Pammer J, Weninger W, Tschachler E. 1998. Human keratinocytes express cellular prion-related protein in vitro and during inflammatory skin disease. Am J Pathol 153:1353-1358.
65. Perovic S, Schröder HC, Pergande G, Ushijima H, Müller WEG. 1997. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126). Exp Neurol 147:518-524.
66. Peyrin J-M, Lasmeezas CI, Haïk S, Tagliavini F, Salmona M, Williams A, Richie D, Deslys J-P, Dormont D. 1999. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 10:723-729.
67. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
68. Prusiner SB. 1991. Molecular biology of prion disease. Science 252: 1515-1522.
69. Raeber A, Race RE, Brandner S, Priola SA, Sailer A, Bessen RA, Mucke L, Manson J, Aguzzi A, Oldstone MBA, Weissmann C, Chesebro B. 1997. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J 16:6057-6065.
70. Salès N, Rodolfo K, Hässig R, Faucheux B, Di Giamberdino L, Moya KL. 1998. Cellular prion protein localization in rodent and primate brain. Eur J Neurosci 10:2464-2471.
71. Tagliavini F, Prelli F, Verga L, Giaccone G, Sarma R, Gorevic P, Ghetti B, Passerini F, Forloni G, Salmona M, Bugiani O, Frangione B. 1993. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 90:9678-9682.
72. White AR, Collins SJ, Maher F, Jobling MF, Stewart LR, Thyer JM, Beyreuther K, Masters CL, Cappai R. 1999. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 155:1723-1730.
73. Williams AE, Lawson LJ, Perry VH, Faser H. 1994a. Characterization of microglial response in murine scrapie. Neuropathol Appl Neurobiol 20:47-55.
74. Williams AE, van Dam A-M, Man-A-Hing WKH, Berkenbosch F, Eikelenboom P, Fraser H. 1994b. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res 654:200-206.
75. Ye X, Carp RI. 1995. The pathological changes in peripheral organs of scrapie-infected animals. Histol Histopathol 10:995-1021.